| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 10/27/2004 | EP1469809A2 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 10/27/2004 | EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 10/27/2004 | EP0866793B1 Nitroimidazole antibacterial compounds and methods of use thereof |
| 10/27/2004 | CN1541218A Fungicidal triazolopyrimidines, method for prodn. thereof and use thereof in controlling noxious fungi and agents containing said compounds |
| 10/27/2004 | CN1541214A Novel compounds |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1539839A Process for prepn. of phthalocyanin compound and intermediate and these intermediate compound |
| 10/27/2004 | CN1172979C Warp-free pigment compositions comprising diaryldiketopyrrolo [3,4-c] pyrroles |
| 10/27/2004 | CN1172934C Process for preparation of 2-amino-5,8-dimethoxy riazolo yrimidine |
| 10/27/2004 | CN1172918C Isothizole derivatives useful anticancer agents |
| 10/26/2004 | US6809202 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 10/26/2004 | US6809200 Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof |
| 10/26/2004 | US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 10/26/2004 | US6809176 Compounds for use in treatment of cancer |
| 10/26/2004 | US6809105 Diazabicyclic central nervous system active agents |
| 10/26/2004 | US6808884 Intercalation compound for use in the diagnosis and detection of genetic disorders |
| 10/26/2004 | CA2303446C Carbapenem derivatives and a preparation method thereof |
| 10/26/2004 | CA2127411C Tricyclic derivatives |
| 10/21/2004 | WO2004090046A1 Fluorescent diketopyrrolopyrroles |
| 10/21/2004 | WO2004089974A1 Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction |
| 10/21/2004 | WO2004089955A1 Pyrimido compounds |
| 10/21/2004 | WO2004089954A1 Novel carbapenem compounds |
| 10/21/2004 | WO2004089931A1 Substituted pyrazoles |
| 10/21/2004 | WO2004089905A1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 10/21/2004 | WO2004089380A2 Pharmaceutical use of fused 1,2,4-triazoles |
| 10/21/2004 | WO2004089378A1 Medicinal composition containing pyrrolopyridazine derivative |
| 10/21/2004 | WO2004089300A2 Sapphyrins and uses thereof |
| 10/21/2004 | WO2004076383A9 Mono amine and diamine derivatives of cl-20 |
| 10/21/2004 | WO2003096980A3 Bicyclic modulators of androgen receptor function |
| 10/21/2004 | WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/21/2004 | US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents |
| 10/21/2004 | US20040210048 Preparation of metal mesoporphyrin halide compounds |
| 10/21/2004 | US20040209898 preparation of the EPCRS form by heating the Risperidone in an organic solvent(s) followed by subsequent cooling and isolation to get desired polymorph |
| 10/21/2004 | US20040209897 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds |
| 10/21/2004 | US20040209895 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases |
| 10/21/2004 | US20040209892 Heterocyclic compounds and methods of use |
| 10/21/2004 | US20040209889 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 10/21/2004 | US20040209887 Pyrrolo[1,2-B]pyridazine compounds and their uses |
| 10/21/2004 | US20040209886 nitrogen compounds such as 3-Cyano-4-[4-(cyano-phenyl-methyl)-phenylamino]-5-methyl-pyrrolo[1,2-b]pyridazine-6-carboxylic acid ethyl ester and optionally with carriers used as antiproliferative agents; enzyme inhibitors |
| 10/21/2004 | US20040209882 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 10/21/2004 | US20040209881 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 10/21/2004 | US20040209880 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |
| 10/21/2004 | US20040209878 7-amino-pyrrazolo[1,5-a]pyrimidine derivatives, useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |
| 10/21/2004 | US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 10/21/2004 | US20040209870 contain 5-HT ligands used to treat central nervous system disorders |
| 10/21/2004 | US20040209865 use for reducing body weight and treating urinary incontinence; Melanin-concentrating hormone (MCH); 5-(4-chloro-phenyl)-2-[5-(2-pyrrolidin-1-yl-ethoxy)-pyridin-2-yl-ethynyl]-pyridine for example |
| 10/21/2004 | US20040209864 Substituted heterocycle fused gamma-carbolines |
| 10/21/2004 | US20040209799 comprises inhibitors (cytokines) of janus kinases (JAK)/signal transducers and activators of transcription (STAT) other than debromohymenialdisine and hymensialdisine; gene expression inhibition; bioassay, immunoassay, drug screening; for treatment of degenerative joint diseases such as osteoarthritis |
| 10/21/2004 | US20040206940 Novel method of preparing nitrogen macrocycles |
| 10/21/2004 | CA2521835A1 Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction |
| 10/21/2004 | CA2521201A1 Substituted pyrazoles for use in the prophylaxis or treatment of a disease which can be influenced by the binding of the substitued pyrazoles to 5ht receptors |
| 10/21/2004 | CA2521124A1 Pyrimido compounds |
| 10/21/2004 | CA2520452A1 Sapphyrins and uses thereof |
| 10/21/2004 | CA2519794A1 Novel carbapenem compounds |
| 10/20/2004 | EP1469001A1 Corroles, including chiral derivatives and the use thereof |
| 10/20/2004 | EP1469000A1 Novel crystalline tricyclic triazolobenzazepine derivative |
| 10/20/2004 | EP1468984A1 Optical resolution process for trifluorolalkylamines with tartaric acid |
| 10/20/2004 | EP1468735A1 Molded catalyst for production of triethylenediamine, method for its production, and method for producing triethylenediamine |
| 10/20/2004 | EP1468050A1 Water-soluble phthalocyanine compound-containing ink for ink jetting, ink jet recording method and method for improving ozone gas discoloration of colored image material |
| 10/20/2004 | EP1467997A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 10/20/2004 | EP1467996A1 Pyrimidotriazines as phosphatase inhibitors |
| 10/20/2004 | EP1467995A2 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/20/2004 | EP1467730A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
| 10/20/2004 | EP1330457B1 Cyclopenta[b][1,4] diazepino[6,7,1-hi]indoles as 5ht2c antagonists |
| 10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 10/20/2004 | EP1140941B1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 10/20/2004 | CN1538848A Novel Benzo-fused heterocycles |
| 10/20/2004 | CN1538847A 4-amino-6-phenyl-pyrrolo [2,3-D] pyrimidine derivatives |
| 10/20/2004 | CN1537854A Method of separating, large scale preparing porphyrin from complex reaction system |
| 10/20/2004 | CN1537853A Synthesis method of 2-amino-6-methyl-5-oxo-4-normal propyl-5-triazole [1,5-alpha] pyrimidine |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171871C 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
| 10/19/2004 | US6806365 N-alkanoylphenylalamine derivatives |
| 10/19/2004 | US6806274 Quinazoline derivatives |
| 10/19/2004 | US6806272 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 10/19/2004 | US6806268 Method for treating glaucoma V |
| 10/19/2004 | US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 10/19/2004 | CA1341460C Production and use of porphyrin derivatives and of compositions containing such derivates |
| 10/14/2004 | WO2004087714A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 10/14/2004 | WO2004087713A1 Salts of tricyclic inhibitors of poly(adp-ribose) polymerases |
| 10/14/2004 | WO2004087712A1 NEW PYRIMIDINE LINKED PYRROLO[2,1-c][1,4]BENZODIAZEPINES AS POTENTIAL ANTITUMOUR AGENTS |
| 10/14/2004 | WO2004087711A1 Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents |
| 10/14/2004 | WO2004087710A1 Pyrrolo`1,2-b!pyridazine compounds and their use as crf1 receptor antagonists |
| 10/14/2004 | WO2004087709A1 Pyrrolo[1,2-b]pyridazine compounds and their uses |
| 10/14/2004 | WO2004087708A1 Pyrrolo (1,2-b) pyridazine compounds and their use as cfr-1 receptor antagonists |
| 10/14/2004 | WO2004087707A1 Pyrazolopyrimidine compounds and their use in medicine |
| 10/14/2004 | WO2004087706A1 7-alkinylamino-triazolopyrimidines, methods for the production and use thereof to combat harmful fungi and agents containing said compounds |
| 10/14/2004 | WO2004087705A1 7-alkenylamino-triazolopyrimidines, method for the production thereof and use thereof in controlling harmful fungi and substances containing said triazolopyrimidines |
| 10/14/2004 | WO2004087652A2 Imidazotriazine compounds |
| 10/14/2004 | WO2004087164A1 8-nitro-tryptanthrin and other tryptanthrin derivatives used for the treatment of diseases caused by highly proliferating cells |
| 10/14/2004 | WO2004087056A2 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ |
| 10/14/2004 | WO2004087053A2 Dipeptidyl peptidase inhibitors |
| 10/14/2004 | WO2004078116A3 P38 inhibitors and methods of use thereof |
| 10/14/2004 | WO2004069256A8 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 10/14/2004 | WO2004052315A3 Tyrosine kinase inhibitors |
| 10/14/2004 | WO2004043367A3 Fused heterocyclic compounds and use thereof |
| 10/14/2004 | US20040204481 Activation of natural killer cells by adenosine A3 receptor agonists |
| 10/14/2004 | US20040204478 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 10/14/2004 | US20040204432 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| 10/14/2004 | US20040204427 Inhibitors of both KDR an FGFR kinases and are selective against LCK; for therapy of solid tumors, in particular breast, colon, lung and prostate tumors. |